desoxycorticosterone acetate has been researched along with metformin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Amara, VR; Surapaneni, SK; Tikoo, K | 1 |
| Gotthardt, M; Granzier, HL; Liss, M; Methawasin, M; Slater, RE; Strom, JG; Sweitzer, N | 1 |
3 other study(ies) available for desoxycorticosterone acetate and metformin
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Metformin attenuates cardiovascular and renal injury in uninephrectomized rats on DOCA-salt: Involvement of AMPK and miRNAs in cardioprotection.
Topics: Acute Kidney Injury; AMP-Activated Protein Kinases; Animals; Desoxycorticosterone Acetate; Hemodynamics; Hypertension; Kidney; Male; Metformin; MicroRNAs; Myocardium; Protective Agents; Rats, Sprague-Dawley; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2019 |
Metformin improves diastolic function in an HFpEF-like mouse model by increasing titin compliance.
Topics: Animals; Desoxycorticosterone Acetate; Diastole; Disease Models, Animal; Heart Failure; Heart Ventricles; Male; Metformin; Mice; Mice, Inbred C57BL; Myocardium; Phosphorylation; Protein Kinases; Stroke Volume | 2019 |